Peter H. Duesberg, a molecular biologist who made key discoveries in cancer research before becoming a leading voice in the debate over HIV and AIDS, died on January 13, 2026, at the age of 89. He passed away in Berkeley, California, where he had spent decades as a professor at the University of California.
Background
Peter Heinz Hermann Duesberg was born on December 2, 1936, in Germany. He studied at the University of Frankfurt and later moved to the United States. In the 1970s, Duesberg gained respect in the scientific world for his work on retroviruses and oncogenes, the genes linked to cancer. He helped map the genetic structure of these viruses and isolated one of the first cancer genes. This put him on track for recognition, including election to the National Academy of Sciences.
By the mid-1980s, as the AIDS crisis grew, Duesberg turned his attention to the disease. In a 1987 article in Cancer Research, he argued that HIV, the virus identified as the cause of AIDS, was not the problem. He called it a harmless passenger virus. Instead, he pointed to drug use, both recreational and medical treatments like AZT, as the real causes of immune system failure in AIDS patients outside Africa.
Duesberg expanded these ideas in his 1996 book, Inventing the AIDS Virus. He claimed AIDS cases in Africa came from poverty, bad water, and infections, not HIV. He said retroviruses like HIV could not harm people because they spread from mother to child without killing hosts. These views put him at odds with most scientists, who saw strong evidence that HIV destroys the immune system and leads to AIDS.
His ideas found some support from figures like Kary Mullis, the Nobel Prize winner for PCR testing. But reviews in journals like Nature and Science called his arguments weak, based on cherry-picked data, and lacking fair review of evidence against him.
Key Details
Duesberg's profile rose in the 1990s through articles, letters, and talks. He never studied HIV directly in his lab but built his case from existing studies. Colleagues saw him as a contrarian who stuck to his guns even as treatments proved HIV's role.
Role in South Africa
In 2000, South African President Thabo Mbeki invited Duesberg to a presidential advisory panel on HIV and AIDS. Mbeki questioned the standard view of the disease. Duesberg joined 44 members, including other skeptics. The panel met during the International AIDS Conference in Durban. This gave the impression of open debate on HIV's role.
Scientists responded with the Durban Declaration, signed by over 5,000 experts. It stated the proof that HIV causes AIDS was clear and complete.
South Africa's government delayed antiretroviral drugs under Mbeki. Two studies later linked this to over 330,000 extra AIDS deaths and 35,000 HIV-infected babies from 2000 to 2005. Duesberg's writings and panel role played a part in these policies.
Duesberg disputed these claims. He noted South Africa's population grew and said HIV did not replicate enough to kill. He called antiviral drugs toxic.
"HIV does not replicate in the body and that antiviral drugs, which he calls 'inevitably toxic,' do not inhibit HIV."
His associate David Rasnick also advised Mbeki and pushed to limit HIV testing and drugs. Rasnick faced court for illegal vitamin trials as AIDS cures.
Duesberg stayed at UC Berkeley, teaching molecular and cell biology. He kept writing and speaking on his hypothesis into recent years. A 2017 photo shows him at a Berkeley cancer meeting. His views spread online and influenced denial groups, though most scientists dismissed them.
What This Means
Duesberg's death closes a long chapter in AIDS history. His early work advanced cancer science, mapping retroviruses that later helped HIV research. But his later claims fueled denialism, a movement that questioned proven treatments at a time when millions needed them.
In South Africa, the policy delays cost lives. Studies pin hundreds of thousands of deaths on the hesitation to use antiretrovirals. This showed how one scientist's credentials could sway leaders, even against consensus.
Denialism persists online today. Groups track denialists, noting over 25 prominent ones who died of AIDS-related illnesses. Psychologists link it to mistrust of medicine and conspiracy ideas.
Duesberg's case highlights tensions in science. Dissent is part of the process, but rejecting broad evidence can have real-world harm. His story reminds of the stakes when science meets policy and public health.
At Berkeley, colleagues remembered his brilliance in retroviruses but noted his shift isolated him. The university listed him as a professor until his death. No immediate word on funeral plans.
His work lives in archives and debates. Books like his 1996 title still circulate. For students, he was a figure of bold challenges, right or wrong. The AIDS field moved on, with treatments saving millions yearly based on HIV's role.
South Africa changed course after Mbeki. New leaders rolled out drugs, cutting deaths sharply. The episode stands as a lesson in evidence versus outlier views.
Duesberg leaves a mixed legacy: pioneer in one era, outlier in another. His passing at 89 ends direct input, but echoes remain in fringe discussions.
